These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 28441936

  • 1. Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients.
    Davies SJ, Caskey FJ, Coyle D, Lindley E, Macdonald J, Mitra S, Wilkie M, Davenport A, Farrington K, Dasgupta I, Ormandy P, Andronis L, Solis-Trapala I, Sim J.
    BMC Nephrol; 2017 Apr 26; 18(1):138. PubMed ID: 28441936
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis: the BISTRO RCT.
    Zanganeh M, Belcher J, Fotheringham J, Coyle D, Lindley EJ, Keane DF, Caskey FJ, Dasgupta I, Davenport A, Farrington K, Mitra S, Ormandy P, Wilkie M, Macdonald JH, Solis-Trapala I, Sim J, Davies SJ, Andronis L.
    Health Technol Assess; 2024 Sep 25; ():1-45. PubMed ID: 39325432
    [Abstract] [Full Text] [Related]

  • 3. Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial.
    Davies SJ, Coyle D, Lindley EJ, Keane D, Belcher J, Caskey FJ, Dasgupta I, Davenport A, Farrington K, Mitra S, Ormandy P, Wilkie M, MacDonald J, Zanganeh M, Andronis L, Solis-Trapala I, Sim J.
    Kidney Int; 2023 Sep 25; 104(3):587-598. PubMed ID: 37263353
    [Abstract] [Full Text] [Related]

  • 4. Bioimpedance spectroscopy-guided fluid management in peritoneal dialysis patients with residual kidney function: A randomized controlled trial.
    Yoon HE, Kwon YJ, Shin SJ, Lee SY, Lee S, Kim SH, Lee EY, Shin SK, Kim YS.
    Nephrology (Carlton); 2019 Dec 25; 24(12):1279-1289. PubMed ID: 30706575
    [Abstract] [Full Text] [Related]

  • 5. Does Routine Bioimpedance-Guided Fluid Management Provide Additional Benefit to Non-Anuric Peritoneal Dialysis Patients? Results from COMPASS Clinical Trial.
    Oh KH, Baek SH, Joo KW, Kim DK, Kim YS, Kim S, Oh YK, Han BG, Chang JH, Chung W, Na KY, Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS) study.
    Perit Dial Int; 2018 Dec 25; 38(2):131-138. PubMed ID: 29386302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Residual kidney function in nocturnal vs conventional haemodialysis patients: a prospective observational study.
    Skeat L, Masterson R, Tjipto AC, Karschimkus C, Toussaint ND.
    Int Urol Nephrol; 2020 Apr 25; 52(4):757-764. PubMed ID: 32124232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial.
    Baek SH, Oh KH, Kim S, Kim DK, Joo KW, Oh YK, Han BG, Chang JH, Chung W, Kim YS, Na KY.
    Trials; 2014 Nov 06; 15():432. PubMed ID: 25376940
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial.
    Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E.
    Am J Kidney Dis; 2013 Jun 06; 61(6):957-65. PubMed ID: 23415416
    [Abstract] [Full Text] [Related]

  • 12. Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial.
    Yan H, Fang W, Lin A, Cao L, Ni Z, Qian J.
    Am J Kidney Dis; 2017 Apr 06; 69(4):506-513. PubMed ID: 27751610
    [Abstract] [Full Text] [Related]

  • 13. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
    Fernández Lucas M, Ruíz-Roso G, Merino JL, Sánchez R, Bouarich H, Herrero JA, Muriel A, Zamora J, Collado A.
    Trials; 2020 Feb 19; 21(1):206. PubMed ID: 32075665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.
    Johnson DW, Clarke M, Wilson V, Woods F, Brown FG.
    BMC Nephrol; 2010 Sep 16; 11():25. PubMed ID: 20843375
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
    Li T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, Dragoi S.
    Am J Nephrol; 2019 Sep 16; 50(6):411-421. PubMed ID: 31630148
    [Abstract] [Full Text] [Related]

  • 19. Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial.
    Hayat A, Cho Y, Hawley CM, Htay H, Krishnasamy R, Pascoe E, Teitelbaum I, Varnfield M, Johnson DW.
    Perit Dial Int; 2023 Sep 16; 43(5):374-382. PubMed ID: 37259236
    [Abstract] [Full Text] [Related]

  • 20. Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters.
    Siriopol D, Hogas S, Voroneanu L, Onofriescu M, Apetrii M, Oleniuc M, Moscalu M, Sascau R, Covic A.
    Nephrol Dial Transplant; 2013 Nov 16; 28(11):2851-9. PubMed ID: 23828163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.